CRISPR technologies for precise epigenome editing

被引:202
|
作者
Nakamura, Muneaki [1 ]
Gao, Yuchen [1 ,2 ,5 ]
Dominguez, Antonia A. [1 ,6 ]
Qi, Lei S. [1 ,3 ,4 ]
机构
[1] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
[2] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA
[4] Stanford Univ, Stanford ChEM H Inst, Stanford, CA 94305 USA
[5] Mammoth Biosci, San Francisco, CA USA
[6] Sana Biotechnol, San Francisco, CA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
DNA METHYLATION; REGULATORY ELEMENTS; GENE-EXPRESSION; CHROMATIN; ENHANCERS; IDENTIFICATION; ACTIVATION; THOUSANDS; BINDING; TARGET;
D O I
10.1038/s41556-020-00620-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Qi and colleagues review CRISPR-based epigenome engineering technologies to modulate histone and DNA modifications and to perturb DNA and RNA regulatory elements and chromatin organization. The epigenome involves a complex set of cellular processes governing genomic activity. Dissecting this complexity necessitates the development of tools capable of specifically manipulating these processes. The repurposing of prokaryotic CRISPR systems has allowed for the development of diverse technologies for epigenome engineering. Here, we review the state of currently achievable epigenetic manipulations along with corresponding applications. With future optimization, CRISPR-based epigenomic editing stands as a set of powerful tools for understanding and controlling biological function.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 50 条
  • [31] Cancer induction and suppression with transcriptional control and epigenome editing technologies
    Shota Nakade
    Takashi Yamamoto
    Tetsushi Sakuma
    Journal of Human Genetics, 2018, 63 : 187 - 194
  • [32] Structural Insights into Crispr and Anti-Crispr Systems for Precise Genome Editing
    Jiang, Fuguo
    Liu, Junjie
    Nogales, Eva
    Bondy-Denomy, Joseph
    Doudna, Jennifer
    PROTEIN SCIENCE, 2018, 27 : 55 - 56
  • [33] Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems
    Taegeun Bae
    Junseok W. Hur
    Dokyoung Kim
    Junho K. Hur
    Genes & Genomics, 2019, 41 : 871 - 877
  • [34] Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems
    Bae, Taegeun
    Hur, Junseok W.
    Kim, Dokyoung
    Hur, Junho K.
    GENES & GENOMICS, 2019, 41 (08) : 871 - 877
  • [35] Editing the Epigenome
    Yeager, Ashley
    SCIENTIST, 2019, 33 (01): : 50 - 53
  • [36] Epigenome editing
    Philipp Voigt
    Danny Reinberg
    Nature Biotechnology, 2013, 31 : 1097 - 1099
  • [37] Epigenome editing
    Voigt, Philipp
    Reinberg, Danny
    NATURE BIOTECHNOLOGY, 2013, 31 (12) : 1097 - 1099
  • [39] Refining CRISPR-based genome and epigenome editing off-targets
    Yonglun Luo
    Cell Biology and Toxicology, 2019, 35 : 281 - 283
  • [40] Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
    Pei, Wen-Di
    Zhang, Yan
    Yin, Tai-Lang
    Yu, Yang
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 215 - 228